Riverside Partners has announced that Kevin Morro has joined the firm as its Head of Business Development. Mr. Morro will oversee all new deal origination, sourcing and marketing functions at the firm.
“We are very excited to have Kevin join our team,” said David Belluck, a general partner at Riverside. “We conducted a national search to fill this position, and Kevin stood out among the many candidates with whom we met. He has spent more than twenty years in business development roles and possesses extensive experience working with technology and healthcare companies in the middle market.”
Mr. Morro succeeds Jon Lemelman, who previously oversaw sourcing at Riverside. Mr. Lemelman will continue to support the firm’s activities as a senior advisor. In addition, Mr. Lemelman will be dedicating significant time to helping manage Classify, a software start-up he recently co-founded.
“Jon has been with us for almost eighteen years and helped drive the success of the firm,” said Mr. Belluck. “We are delighted that Jon will continue as an advisor to the firm, and we fully support him as he pursues his passion for software start-ups.”
Prior to joining Riverside, Mr. Morro spent the past fourteen years at H.I.G. Capital, most recently serving as its Director of Business Development focused on the firm’s middle-market and advantage funds. Mr. Morro earned his undergraduate degree from Fordham University.
“Kevin is a great fit with the culture and values of Riverside Partners,” said Steven Kaplan, a general partner at Riverside. “Kevin will oversee our business development efforts with bankers, brokers and other deal sources as well as our proprietary deal sourcing efforts.”
Riverside makes control investments in middle-market healthcare and technology-oriented companies that have EBITDAs from $3 million to $15 million. The Boston-headquartered firm is currently investing from its sixth fund.
Last week, Riverside announced the acquisition Sequoia Consulting Group, a San Diego-headquartered provider of life sciences-related consulting services from early-stage research and development through commercial operations. The company’s customers include biotech, pharma, diagnostic, and medical device companies.
Riverside was founded in 1989 and is headquartered in Boston.
© 2022 Private Equity Professional | January 27, 2022
